Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-1993 | 12-1992 | 09-1992 | 06-1992 | 03-1992 | |
Cash Flows From Operating Activities | |||||
Net Income | -14,082 | N/A | N/A | N/A | -4,517 |
Depreciation Amortization | 1,706 | N/A | N/A | N/A | 1,018 |
Other Working Capital | 3,484 | N/A | N/A | N/A | -183 |
Other Operating Activity | -4 | 0 | 0 | 0 | -26 |
Operating Cash Flow | $-8,896 | $N/A | $N/A | $N/A | $-3,708 |
Cash Flows From Investing Activities | |||||
PPE Investments | -4,361 | N/A | N/A | N/A | -506 |
Other Investing Activity | -119,732 | 0 | 0 | 0 | -17,496 |
Investing Cash Flow | $-124,093 | $N/A | $N/A | $N/A | $-18,002 |
Cash Flows From Financing Activities | |||||
Other Financing Activity | 47,190 | 0 | 0 | 0 | 99,321 |
Financing Cash Flow | $47,190 | $N/A | $N/A | $N/A | $99,321 |
Beginning Cash Position | 87,923 | N/A | N/A | N/A | 10,312 |
End Cash Position | 2,125 | N/A | N/A | N/A | 87,923 |
Net Cash Flow | $-85,798 | $N/A | $N/A | $N/A | $77,611 |
Free Cash Flow | |||||
Operating Cash Flow | -8,896 | N/A | N/A | N/A | -3,708 |
Free Cash Flow | -8,896 | 0 | 0 | 0 | -3,708 |